Cargando…

Dioscin Ameliorates Hyperuricemia-Induced Atherosclerosis by Modulating of Cholesterol Metabolism through FXR-Signaling Pathway

Hyperuricemia is one of the independent risk factors for atherosclerotic cardiovascular disease. Herein, we investigate the association between uric acid and cholesterol metabolism and the effect of dioscin on the prevention of hyperuricemia-induced atherosclerosis. In the potassium oxonate-treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Ruixia, Wang, Wei, Chen, Beibei, Pan, Jujie, Chen, Qian, Liu, Mengyang, Wang, Dan, Wu, Yuzheng, Yu, Haiyang, Han, Lifeng, Zhang, Yi, Wang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101489/ https://www.ncbi.nlm.nih.gov/pubmed/35565954 http://dx.doi.org/10.3390/nu14091983

Ejemplares similares

Pseudohypoadrenalism, a subclinical cortisol metabolism disorder in hyperuricemia
por: Bao, Ruixia, et al.
Publicado: (2023)

The Time-Feature of Uric Acid Excretion in Hyperuricemia Mice Induced by Potassium Oxonate and Adenine
por: Wen, Shaoshi, et al.
Publicado: (2020)

Effect of Eurycoma longifolia Stem Extract on Uric Acid Excretion in Hyperuricemia Mice
por: Bao, Ruixia, et al.
Publicado: (2019)

FXR an emerging therapeutic target for the treatment of atherosclerosis
por: Mencarelli, Andrea, et al.
Publicado: (2010)

Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling
por: Pan, Linyu, et al.
Publicado: (2023)

Recent Advances in the Pharmacological Activities of Dioscin
por: Yang, Longfei, et al.
Publicado: (2019)

Ginsenoside Compound K Ameliorates Development of Diabetic Kidney Disease through Inhibiting TLR4 Activation Induced by Microbially Produced Imidazole Propionate
por: Chen, Qian, et al.
Publicado: (2022)

Dioscin ameliorates slow transit constipation in mice by up-regulation of the BMP2 secreted by muscularis macrophages
por: Ren, BingBing, et al.
Publicado: (2022)

Discovery of 9,11-Seco-Cholesterol Derivatives as Novel FXR Antagonists
por: Zhou, Jia-Xu, et al.
Publicado: (2022)

Notopterol Ameliorates Hyperuricemia-Induced Cardiac Dysfunction in Mice
por: Wang, Qian, et al.
Publicado: (2023)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
por: Ye, Xin, et al.
Publicado: (2022)

Dioscin Inhibits Virulence Factors of Candida albicans
por: Yang, Longfei, et al.
Publicado: (2018)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
por: Cui, Shuang, et al.
Publicado: (2023)

Dioscin Regulating Bone Marrow Apoptosis in Aplastic Anemia
por: Zhang, Le, et al.
Publicado: (2022)

Dioscin alleviates the progression of osteoarthritis: an in vitro and in vivo study
por: Ding, Qing, et al.
Publicado: (2023)

Neuroprotective Effect of Dioscin on the Aging Brain
por: Qi, Yan, et al.
Publicado: (2019)

Mechanism of dioscin ameliorating renal fibrosis through NF‑κB signaling pathway‑mediated inflammatory response
por: Wang, Yang, et al.
Publicado: (2023)

Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions
por: Chen, Sy-Jou, et al.
Publicado: (2019)

The Establishment and Characteristics of Rat Model of Atherosclerosis Induced by Hyperuricemia
por: Liu, Zhen, et al.
Publicado: (2016)

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
por: Li, Yun, et al.
Publicado: (2021)

Effects of Allium mongolicum Regel and Its Flavonoids on Constipation
por: Chen, Yue, et al.
Publicado: (2019)

Ameliorative effect of cheqianzi decoction on hyperuricemia and kidney injury and underlying mechanism in rats
por: Meng, Jing, et al.
Publicado: (2023)

Dioscin ameliorates inflammatory bowel disease by up‐regulating miR‐125a‐5p to regulate macrophage polarization
por: Shi, Lingyan, et al.
Publicado: (2022)

Potent effects of dioscin against liver fibrosis
por: Zhang, Xiaoling, et al.
Publicado: (2015)

Potent effects of dioscin against obesity in mice
por: Liu, Min, et al.
Publicado: (2015)

Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system
por: Wen, Guanmei, et al.
Publicado: (2022)

Dioscin Ameliorates Experimental Autoimmune Thyroiditis via the mTOR and TLR4/NF-κB Signaling
por: Zhang, Chengfei, et al.
Publicado: (2023)

Dioscin: A new potential inhibitor of Skp2 for cancer therapy
por: Jiang, Wenxiao, et al.
Publicado: (2020)

Correction for Ye et al., “FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains”
por: Ye, Xin, et al.
Publicado: (2023)

N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models
por: Li, Lanzhou, et al.
Publicado: (2019)

Corrigendum: Potent effects of dioscin against obesity in mice
por: Liu, Min, et al.
Publicado: (2015)

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
por: Yang, Minghua, et al.
Publicado: (2023)

FXR-Mediated Cortical Cholesterol Accumulation Contributes to the Pathogenesis of Type A Hepatic Encephalopathy
por: McMillin, Matthew, et al.
Publicado: (2018)

Regulation effects of total flavonoids in Morus alba L. on hepatic cholesterol disorders in orotic acid induced NAFLD rats
por: Hu, Yucheng, et al.
Publicado: (2020)

Weighted Gene Co-expression Network Analysis of the Dioscin Rich Medicinal Plant Dioscorea nipponica
por: Sun, Wei, et al.
Publicado: (2017)

Autophagy Inhibition Enhances Apoptosis Induced by Dioscin in Huh7 Cells
por: Hsieh, Ming-Ju, et al.
Publicado: (2012)

Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior
por: Huang, Fei, et al.
Publicado: (2015)

HuangQi ChiFeng decoction maintains gut microbiota and bile acid homeostasis through FXR signaling to improve atherosclerosis
por: Fu, Jiaqi, et al.
Publicado: (2023)

Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia
por: Wang, Ruoyu, et al.
Publicado: (2022)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_prmjrni4kvqkev3dfnnq252m8m